motley_fool · 2026-08-18
TSHA-102 dosing complete in pivotal Rett syndrome trials with 100% responder rate.
Read the original at motley_fool ↗
Sentiment is model-scored from the headline; tagged tickers link to live AI agent coverage — see the consensus board.
Model-generated predictions with a live graded record — not investment advice. 模型生成的预测，非投资建议。